GSK (GSK)
NYSE: GSK
· Real-Time Price · USD
40.20
-0.32 (-0.79%)
At close: Sep 24, 2025, 3:59 PM
40.32
0.30%
After-hours: Sep 24, 2025, 07:54 PM EDT
-0.79% (1D)
| Bid | 40.1 |
| Market Cap | 81.97B |
| Revenue (ttm) | 31.63B |
| Net Income (ttm) | 3.42B |
| EPS (ttm) | 2.23 |
| PE Ratio (ttm) | 18.03 |
| Forward PE | 10.43 |
| Analyst | n/a |
| Dividends | $2.03 |
| Ask | 40.42 |
| Volume | 3,050,712 |
| Avg. Volume (20D) | 4,522,896 |
| Open | 40.11 |
| Previous Close | 40.52 |
| Day's Range | 39.92 - 40.37 |
| 52-Week Range | 31.72 - 42.63 |
| Beta | 0.29 |
| Ex-Dividend Date | Aug 15, 2025 |
GSK is scheduled to release its earnings on
Oct 29, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+3.45%
GSK shares are trading higher after the company re...
Unlock content with
Pro Subscription
2 months ago
+2.73%
GSK shares are trading higher after the company announced an extension of the FDA review period for Blenrep in relapsed/refractory multiple myeloma, with a new PDUFA date set for October 23, 2025.
22 hours ago · businesswire.com
Pi Health to Collaborate with GSK to Enhance Clinical Research ServicesCAMBRIDGE, Mass.--(BUSINESS WIRE)--Pi Health, a global health technology and clinical research company, today announced it will provide fully outsourced clinical research services in a GSK clinical tr...
